Affiliation:
1. Faculdade de Farmácia, Universidade Federal Fluminense – Universidade Federal Fluminense, Niterói, Brazil
2. Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil
3. Clínicas Oncológicas Integradas (COI), Barra Medical Center Av. das Américas, Rio de Janeiro, Brazil
Abstract
Introduction Patients with cancer need care from a multidisciplinary team due to the complexity of the clinical picture and proposed treatment. Hospital discharge is a critical step, because pharmacotherapy changes may occur during hospitalization, leading to potential medication-related problems at home. Objective To identify publications which describe the activities performed by the pharmacist at the hospital discharge of patients with cancer. Method This is an integrative systematic literature review. A search was carried out in the MEDLINE databases, via Pubmed, Embase, and Virtual Health Library, using the following descriptors: “Patient Discharge”, “Pharmacists”, “Neoplasms.” Studies that reported activities performed by the pharmacist at the hospital discharge of patients with cancer were included. Results Five hundred and two studies were identified, of which seven met the eligibility criteria. Most were conducted in the United States (n = 3), and the rest in Belgium, Brazil, Canada, and Italy. Among the services provided by the pharmacist at discharge, medication reconciliation was the most widely described. Other activities such as counseling, education, identification, and resolution of drug-related problems were also carried out. Conclusion In the scenario of hospital discharge of patients with cancer, the participation of pharmacists is still to be seen as of significance in regards to publications. Despite this, the results suggest that the actions of this professional contribute to patient orientation and the safe use of prescription drugs for use at home.
Subject
Pharmacology (medical),Oncology
Reference29 articles.
1. World Health Organization, https://www.who.int/health-topics/cancer#tab=tab_1 (2020, accessed 6 December 2021).
2. Proportion of cancer cases and deaths attributable to lifestyle risk factors in Brazil